We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.1B
AUM Growth
-$3.19M
Cap. Flow
+$7.15M
Cap. Flow %
0.65%
Top 10 Hldgs %
43.88%
Holding
196
New
25
Increased
25
Reduced
18
Closed
22

Top Sells

Rank Stock Value
1
QURE icon
uniQure
QURE
+$15.9M
2
PCG icon
PG&E
PCG
+$12.8M
3
STNG icon
Scorpio Tankers
STNG
+$10.5M
4
TRUE
TrueCar
TRUE
+$6.45M
5
BX icon
Blackstone
BX
+$5.95M

Sector Composition

Rank Sector Weight
1 Healthcare 22.77%
2 Consumer Discretionary 14.6%
3 Financials 5.74%
4 Energy 5.41%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWNKW
51
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$4.79M 0.44%
2,520,000
INTC icon
52
PUT
Intel
INTC
$413B
$4.79M 0.44%
+100,000
New +$4.96M
KR icon
53
Kroger
KR
$36.7B
$4.45M 0.4%
205,000
MRKR icon
54
Marker Therapeutics
MRKR
$18.5M
$4.43M 0.4%
56,000
-90,000
-62% -$5.35M
TGTX icon
55
TG Therapeutics
TGTX
$8.19B
$4.28M 0.39%
495,000
-30,000
-6% -$227K
ADVM
56
DELISTED
Adverum Biotechnologies
ADVM
$4.27M 0.39%
35,899
-340
-0.9% -$28.1K
NMCI
57
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$4.2M 0.38%
2,159,243
+102,058
+5% +$216K
SYRS
58
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.98M 0.36%
+42,978
New +$2.99M
FENC icon
59
Fennec Pharmaceuticals
FENC
$335M
$3.88M 0.35%
971,351
ARDX icon
60
Ardelyx
ARDX
$1.24B
$3.88M 0.35%
1,442,346
+405,942
+39% +$1.22M
GM icon
61
General Motors
GM
$80.9B
$3.85M 0.35%
+100,000
New +$3.75M
DSSI
62
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$3.83M 0.35%
300,200
+199,474
+198% +$2.47M
GGAL icon
63
Galicia Financial Group
GGAL
$7.89B
$3.73M 0.34%
105,000
VRDN icon
64
Viridian Therapeutics
VRDN
$2.2B
$3.62M 0.33%
117,736
AMR icon
65
Alpha Metallurgical Resources
AMR
$1.77B
$3.46M 0.31%
66,625
T icon
66
PUT
AT&T
T
$164B
$3.35M 0.3%
132,400
+130,811
+8,232% +$3.14M
IRCP
67
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$3.33M 0.3%
699,672
+13,761
+2% +$60K
SDRL
68
DELISTED
Seadrill Limited Common Stock
SDRL
$3.11M 0.28%
746,951
CDLX icon
69
Cardlytics
CDLX
$22.2M
$3.06M 0.28%
+11,789
New +$2.36M
DHT icon
70
DHT Holdings
DHT
$2.99B
$3.04M 0.28%
515,000
OTIC
71
DELISTED
Otonomy, Inc.
OTIC
$3.02M 0.28%
1,100,000
SBBP
72
DELISTED
Strongbridge Biopharma plc.
SBBP
$2.89M 0.26%
923,700
+75,000
+9% +$275K
NOV icon
73
NOV
NOV
$6.84B
$2.89M 0.26%
130,000
TRAW icon
74
Traws Pharma
TRAW
$7.34M
$2.75M 0.25%
2,578
ROAN
75
DELISTED
Roan Resources, Inc.
ROAN
$2.57M 0.23%
+1,475,837
New +$5.33M

Similar funds

683 Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, 683 Capital Management held 196 positions worth $1.1B, down 0.29% from $1.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

683 Capital Management's Q2 2019 filing shows 25 new, 25 increased, 18 reduced and 22 closed positions. Its largest new stake was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M. The largest sale was uniQure, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • 683 Capital Management's largest Q2 2019 buy was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M.
  • 683 Capital Management added most to Adient in Q2 2019, an estimated $5.66M increase.
  • 683 Capital Management's biggest Q2 2019 reduction was uniQure, cutting an estimated $15.9M.
  • 683 Capital Management fully exited Blackstone in Q2 2019, selling an estimated $5.95M.
  • 683 Capital Management's ten largest holdings make up 44% of its $1.1B portfolio in Q2 2019.
  • 683 Capital Management opened 25 new positions and closed 22 in Q2 2019.
  • 683 Capital Management's portfolio value fell 0.29% quarter-over-quarter to $1.1B.

Based on 683 Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.